Ellie Urenko ’25 pitched Intuitive Surgical Inc. (NASDAQ: ISRG) on October 28, 2024. Intuitive Surgical designs, manufactures, and markets robotic surgical systems aimed at enhancing clinical outcomes through minimally invasive procedures. Intuitive has placed over 9,500 da Vinci Surgical Systems in 71 countries, facilitating over 14.2 million procedures. The company holds a dominant market share and is a global leader in the robotic-assisted surgery space. Intuitive continuously innovates its da Vinci system and has expanded its offerings beyond surgery to include the Ion Endoluminal System, a robotic-assisted, catheter-based platform for minimally invasive biopsies of the lung.
Ellie’s investment thesis highlighted the increasing adoption of robotic-assisted surgery, driven by its proven benefits of enhanced precision, dexterity, and efficiency, which result in fewer complications and shorter hospital stays. During the company’s third quarter earnings call, it projected 17% year-over year revenue growth, expecting this trend to continue in 2025, driven by the full release of the da Vinci 5 Surgical System.
Due to the Intuitive Surgical stock currently trading at an all time high, SMIF decided to track the performance of Intuitive for the remainder of the semester.